About Belsar Plus 40 mg+12.5 mg Tablet
Made by Beacon Pharmaceuticals PLC, Belsar Plus is a tablet whose active ingredient is Olmesartan Medoxomil + Hydrochlorothiazide. It is a combined antihypertensive preparation, meaning it contains two medicines that work in different ways.
There are 4 brands of Olmesartan Medoxomil + Hydrochlorothiazide listed in Bangladesh. 2 of them have a lower unit price than Belsar Plus. The lowest listed price is Abetis Plus 20 mg+12.5 mg Tablet at ৳ 11.00 per unit.
What is Belsar Plus 40 mg+12.5 mg Tablet?
The tablet Belsar Plus contains Olmesartan Medoxomil + Hydrochlorothiazide and is made by Beacon Pharmaceuticals PLC. Hydrochlorothiazide is a diuretic that helps remove excess salt and water from the body, further reducing blood pressure. Olmesartan works by blocking the action of angiotensin II, a substance that narrows blood vessels, so vessels relax and blood pressure falls. Use it only as your doctor directs.
Uses of Belsar Plus
It is a combined antihypertensive preparation, meaning it contains two medicines that work in different ways. It helps lower blood pressure, which can reduce the risk of health problems associated with high blood pressure. Belsar Plus is used to treat high blood pressure (hypertension). Your doctor will decide if this medicine is suitable for you and will monitor your progress.
How to use Belsar Plus
Belsar Plus is a tablet taken by mouth. Swallow the tablet with water. Swallow the tablet as advised. If you miss a dose or are unsure how to take it, ask your doctor or pharmacist for guidance. The doctor decides the dose, how often it is taken and how long the course lasts, and may adjust these over time depending on the blood pressure response.
Side effects of Belsar Plus
If you notice any side effect or it bothers you, tell your doctor or pharmacist. Common ones include nausea, headache, dizziness, high uric acid levels, and infections of the upper respiratory or urinary tract. Side effects that may occur with Belsar Plus include nausea, headache, dizziness, hyperuricemia, upper respiratory tract infection and urinary tract infection. Tell your doctor if you notice any of these or anything else that worries you, and ask when you should call the doctor about them. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
The safety of this medicine in pregnancy and breastfeeding has not been established, so it should be discontinued during these conditions. Belsar Plus should not be used by anyone hypersensitive to any of its ingredients, and because of the hydrochlorothiazide component it should not be used by people with anuria or hypersensitivity to other sulfonamide-derived drugs. Periodic checks of serum electrolytes may be needed to detect electrolyte imbalance. Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Belsar Plus treat?
It is a combined antihypertensive preparation, meaning it contains two medicines that work in different ways. It helps lower blood pressure, which can reduce the risk of health problems associated with high blood pressure.
How do I use Belsar Plus correctly?
Belsar Plus is a tablet taken by mouth. Swallow the tablet with water.
What are the side effects of Belsar Plus?
If you notice any side effect or it bothers you, tell your doctor or pharmacist. Common ones include nausea, headache, dizziness, high uric acid levels, and infections of the upper respiratory or urinary tract.
What is the price of Belsar Plus?
The listed price is ৳ 17.00.
- Strength
- 40 mg+12.5 mg
Price in Bangladesh
৳ 16.66 ৳ 17.00 2% off unit price
Price updated: 18 Nov 2026
Indications
Olmesartan Medoxomil & Hydrochlorothiazide combination is indicated for the treatment of hypertension.
Pharmacology
Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).
Hydrochlorothiazide is a thiazide diuretic. Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing the excretion of Sodium and Chloride in approximately equivalent amounts. Indirectly, the diuretic action of Hydrochlorothiazide reduces plasma volume with consequent increases in plasma renin activity, increases Aldosterone secretion & urinary Potassium loss and decreases serum Potassium. The renin-aldosterone link is mediated by angiotensin-II. So, co-administration of an angiotensin-II receptor antagonist tends to reverse the potassium loss associated with these diuretics.
Dosage & Administration
Hypertension: The usual starting dose is 20/12.5 mg one tablet once daily. Dosing should be individualized. Depending on the blood pressure response, the dose may be titrated at intervals of 2-4 weeks to two tablets 40/25 once daily.
Interaction
Olmesartan: No significant drug interactions were reported in studies in which Olmesartan Medoxomil was co-administered with hydrochlorothiazide, digoxin or warfarin in healthy volunteers. Olmesartan Medoxomil is not metabolized by the cytochrome P450 system and has no effects on P450 enzymes; thus, interactions with drugs that inhibit, induce or are metabolized by those enzymes are not expected.
Hydrochlorothiazide: When administered concurrently, the following drugs may interact with Thiazide diuretics:
- Alcohol, Barbiturates or Narcotics: Potentiation of orthostatic hypotension may occur.
- Antidiabetic drugs (oral agents and Insulin): Dosage adjustment of the antidiabetic drug may be required.
- Other antihypertensive drugs: Additive effect.
- Corticosteroids, ACTH.
- Lithium.
Contraindications
The combination of Olmesartan and Hydrochlorothiazide is contraindicated in patients who are hypersensitive to any component of this product. Because of the Hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.
Side Effects
The common side-effects are nausea, headache, dizziness, hyperuricemia, upper respiratory tract infection and urinary tract infection. Other adverse effects are chest pain, back pain, peripheral edema, abdominal pain, dyspepsia, gastroenteritis, diarrhea.
Pregnancy & Lactation
Safety and effectiveness in nursing mother & pregnancy have not been established. The drug should be discontinued during these conditions.
Precautions & Warnings
- Periodic determination of serum electrolytes should be performed at appropriate intervals to detect possible electrolyte imbalance like hypokalemia, hyponatremia and hypochloremic alkalosis.
- Hyperuricemia may occur in certain patients receiving thiazide therapy.
- Impaired renal function.
Overdose Effects
Olmesartan: Limited data are available in regard to overdosage in humans. The most likely manifestation of overdosage would be hypotension and tachycardia. Supportive treatment should be instituted.
Hydrochlorothiazide: The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, and dehydration) resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias.
Storage Conditions
Store in a cool and dry place, protect from light and moisture. Keep out of the reach of children.
Alternative brands of Olmesartan Medoxomil + Hydrochlorothiazide
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.